Table.
| Sex | Procedures | Timing |
|---|---|---|
| Male | Standard of care | |
| • Sperm cryopreservation | • 1–2 days before cancer therapy | |
| Experimental | ||
| •Gonadal suppression (GnRH Analogs) |
• Concomitant with cancer therapy | |
| • Testicular tissue cryopreservation |
• Before cancer therapy | |
| Female | Standard of care | |
| • Embryo or oocyte cryopreservation |
• 2 weeks before cancer therapy; possible second opportunity at least 4–6 months post-treatment |
|
| • Fertility-sparing surgery | • Concomitant with cancer surgery | |
| • Ovarian transposition | • Before abdomino-pelvic radiation | |
| • Ovarian shielding | • Concomitant with abdomino-pelvic radiation |
|
| Experimental | ||
| • Gonadal suppression (GnRH Analogs) |
• During chemotherapy | |
| • Ovarian tissue cryopreservation | • Before cancer therapy |